Cadila Pharmaceuticals introduces iron supplement Militol

The supplement contains Ferric Maltol, an innovative low-dose form of Ferric iron complexed with Maltol

Cadila Pharmaceuticals, a leader in the pharmaceutical industry, has launched Militol, an innovative iron supplement designed to provide a precise combination of nutrients that maximise absorption and enhance tolerance, effectively addressing iron deficiency.

Militol’s unique formula incorporates carefully selected ingredients to enhance iron absorption and improve overall health. The supplement contains Ferric Maltol, an innovative low-dose form of Ferric iron complexed with Maltol. Militol also includes Folic Acid to promote red blood cell production, Vitamin B12 for neurological health and red blood cell formation, Vitamin C to enhance iron absorption and support immune health, and Vitamin D to boost calcium absorption and promote bone health.

Militol sets itself apart by combining a novel non-salt complex of Ferric iron Maltol, optimising absorption and minimising gastrointestinal side effects commonly associated with iron supplements.  Militol offers comprehensive nutrient support with Folic Acid and multiple vitamins, providing a holistic approach to supplementation. The formulation enhances the absorption of iron and also supports a broad spectrum of nutritional needs, making it both highly effective and well-tolerated for a wide range of patients.